Search

Search Constraints

You searched for: Author/Creator Yu, Bei

Search Results

1. 071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch® prescribing program. Issue 6 (24th May 2018)

6. Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop. Issue 5 (28th March 2020)

9. Documenting business-to-consumer (B2C) communications on Facebook: What have changed among restaurants and consumers?. (8th June 2015)